Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 12
Submit an article Journal homepage
1,844
Views
12
CrossRef citations to date
0
Altmetric
Letters

Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response

Areti Tychalaa Department of Microbiology, Ahepa University Hospital, Thessaloniki, GreeceView further author information
,
Georgios Meletisa Department of Microbiology, Ahepa University Hospital, Thessaloniki, GreeceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8750-513XView further author information
ORCID Icon,
Eugenia Katsimpourliab Department of Immunology, General Hospital G. Papanikolaou, Exohi Thessaloniki, GreeceView further author information
,
Ioanna Gkekaa Department of Microbiology, Ahepa University Hospital, Thessaloniki, GreeceView further author information
,
Rodoula Dimitriadoua Department of Microbiology, Ahepa University Hospital, Thessaloniki, GreeceView further author information
,
Eleni Sidiropouloua Department of Microbiology, Ahepa University Hospital, Thessaloniki, GreeceView further author information
&
Lemonia Skouraa Department of Microbiology, Ahepa University Hospital, Thessaloniki, GreeceView further author information
 show all
Pages 5148-5149 | Received 17 Sep 2021, Accepted 05 Oct 2021, Published online: 29 Oct 2021

References

  • Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, Schaefer-Babajew D, Cipolla M, Gaebler C, Lieberman JA, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592(7855):616–22. doi:10.1038/s41586-021-03324-6.
  • Favresse J, Bayart JL, Mullier F, Dogné JM, Closset M, Douxfils J. Early antibody response in health-care professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2). Clin Microbiol Infect. 2021:S1198-743X(21)00224-X. doi:10.1016/j.cmi.2021.05.004.
  • Espi M, Charmetant X, Barba T, Koppe L, Pelletier C, Kalbacher E, Chalencon E, Mathias V, Ovize A, Cart-Tanneur E, et al. The ROMANOV study found impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis. Kidney Int. 2021:S0085-2538(21)00679–7. doi:10.1016/j.kint.2021.07.005.
  • Schwarz T, Tober-Lau P, Hillus D, Helbig ET, Lippert LJ, Thibeault C, Koch W, Landgraf I, Michel J, Bergfeld L, et al. Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany. Emerg Infect Dis. 2021;27(8):2174–78. doi:10.3201/eid2708.211145.
  • Haberman RH, Herati R, Simon D, Samanovic M, Blank RB, Tuen M, Koralov SB, Atreya R, Tascilar K, Allen JR, et al. Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis. 2021:annrheumdis-2021-220597. doi:10.1136/annrheumdis-2021-220597.
  • Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, Morales M, Ziv T, Shorer Arbel Y, Scarfò L, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165–73. doi:10.1182/blood.2021011568.
  • Schmidt T, Klemis V, Schub D, Schneitler S, Reichert MC, Wilkens H, Sester U, Sester M, Mihm J. Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients. Am J Transplant. 2021. Online ahead of print. doi:10.1111/ajt.16818.
  • Goletti D, Petrone L, Manissero D, Bertoletti A, Rao S, Ndunda N, Sette A, Nikolayevskyy V. The potential clinical utility of measuring SARS-CoV-2-specific T-cell responses. Clin Microbiol Infect. 2021:S1198-743X(21)00378–5. doi:10.1016/j.cmi.2021.07.005.
  • Van Praet JT, Stefaan Vandecasteele S, De Roo A, De Vriese AS, Reynders M. Humoral and cellular immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in nursing home residents. Clin Infect Dis. 2021:ciab300. doi:10.1093/cid/ciab300.
  • Jaganathan S, Stieber F, Rao SN, Nikolayevskyy V, Manissero D, Allen N, Boyle J, Howard J. Preliminary evaluation of QuantiFERON SARS-CoV-2 and QIAreach anti-SARS-CoV-2 total test in recently vaccinated individuals. Infect Dis Ther. 2021:1–12. doi:10.1007/s40121-021-00521-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.